
Consider buying NVIDIA (NVDA) on market dips, as it is viewed as a top-tier company leading the AI revolution with massive, ongoing demand for its hardware. Another high-conviction opportunity is Palantir (PLTR), a high-growth company whose accelerating revenue and strong cash flow may justify its valuation. Conversely, exercise extreme caution with the Quantum Computing sector, which is seen as fundamentally overhyped and far from commercial viability. Specifically, consider avoiding or shorting stocks like IonQ (IONQ) and D-Wave (QBTS), as they are viewed as highly speculative and potentially fraudulent. For a higher-risk, long-term biotech play, look into accumulating Biohaven (BHVN) during its current weakness, betting on its strong management to navigate recent setbacks.

By @realmartinshkreli
Investing, music, science, math, technology, programming, medicine and more!